Glioma Clinical Trials in Middletown, New Jersey
6 recruitingMiddletown, New Jersey
Showing 1–6 of 6 trials
Recruiting
Phase 2
Testing the Anti-cancer Drug Erdafitinib for Brain Cancers That Have Returned or Progressed Following Treatment
Recurrent GliomaRecurrent WHO Grade 2 GliomaRecurrent WHO Grade 3 Glioma+1 more
National Cancer Institute (NCI)30 enrolled27 locationsNCT05859334
Recruiting
Phase 1Phase 2
A Study of Mirdametinib in People With Central Nervous System Tumors
GliomaCentral Nervous System Tumors
Memorial Sloan Kettering Cancer Center26 enrolled7 locationsNCT07539441
Recruiting
Phase 1
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors
MelanomaThyroid CancerGlioma
Pfizer124 enrolled77 locationsNCT05538130
Recruiting
Phase 2
Pembrolizumab, Olaparib, and Temozolomide for People With Glioma
Glioma
Memorial Sloan Kettering Cancer Center57 enrolled10 locationsNCT05188508
Recruiting
Phase 1
A Study of 177Lu-PSMA-617 in People With Gliomas
GliomaGlioblastoma, IDH-wildtypeDiffuse Midline Glioma, H3 K27-Altered+1 more
Memorial Sloan Kettering Cancer Center20 enrolled7 locationsNCT07223034
Recruiting
Glioma Developmental and HyperActive Ras Tumor (DHART) Board
Glioma
Memorial Sloan Kettering Cancer Center50 enrolled7 locationsNCT05489783